JULY 2019 – Cantabria Labs has acquired DEUTRA, an innovative company involved in the study and creation of quality products for clinical nutrition for more than a decade.
DEUTRA products will be incorporated into the Cantabria Labs portfolio with the aim of developing the DEUTERA brand on an international level, using and promoting the quality of the products, which are formulated with carefully selected raw materials. With this acquisition, Cantabria Labs has taken an ambitious step in becoming part of the clinical nutrition sector in Italy. The focus will be on addressing all specialists, professionals and experts involved in clinical nutrition in order to guide the client-patient towards the best choices in terms of therapy, health and life. Cantabria Labs, celebrate life With innovative products and entrepreneurial spirit, Cantabria Labs is an important name in dermatological prescription treatments in Europe, now also in the clinical nutrition sector (a leader in Spain, Italy and Portugal), with a mission to improve people’s health and quality of life. Its presence in more than 80 countries, and its branches in France, China, Italy, Morocco, Mexico and Portugal have contributed to its fame and international recognition. Cantabria Labs production plants are characterised by the highest quality standards for the manufacturing and distribution of more than 30 million units. Cantabria Labs is founded on entrepreneurship, unconventionality and positivity, with the aim of offering society products that allow a life of quality: “celebrate life”.